Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$673M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Linde
LIN
|
+$512M |
| 4 |
Walt Disney
DIS
|
+$502M |
| 5 |
Flutter Entertainment
FLUT
|
+$458M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum China
YUMC
|
+$514M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$465M |
| 3 |
Workday
WDAY
|
+$424M |
| 4 |
Synopsys
SNPS
|
+$408M |
| 5 |
Adobe
ADBE
|
+$396M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.56% |
| 2 | Financials | 12.21% |
| 3 | Industrials | 11.9% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Precigen
PGEN
$2.45B
| $64.7K | ﹤0.01% |
44,612
+129
| +0.3% | +$185 |
|
|
SCPH
3677
DELISTED
scPharmaceuticals
SCPH
| $63.8K | ﹤0.01% |
12,703
-72
| -0.6% | -$403 |
|
3678
ThredUp
TDUP
$416M
| $63.1K | ﹤0.01% |
31,546
-1,051
| -3% | -$2.14K |
|
3679
Standard BioTools
LAB
$311M
| $63K | ﹤0.01% |
23,264
+11,279
| +94% | +$27.2K |
|
|
GBIO
3680
DELISTED
Generation Bio
GBIO
| $62.8K | ﹤0.01% |
1,543
-6,272
| -80% | -$148K |
|
3681
Tenaya Therapeutics
TNYA
$167M
| $62.4K | ﹤0.01% |
11,926
-793
| -6% | -$3.79K |
|
3682
NuScale Power
SMR
$3.78B
| $61.8K | ﹤0.01% |
11,642
-265
| -2% | -$951 |
|
3683
GrowGeneration
GRWG
$87.1M
| $60.8K | ﹤0.01% |
21,265
-100,784
| -83% | -$232K |
|
3684
Erasca
ERAS
$6.25B
| $60.3K | ﹤0.01% |
29,254
-2,544
| -8% | -$5.08K |
|
3685
Nerdy
NRDY
$93.4M
| $59.9K | ﹤0.01% |
20,587
-151
| -0.7% | -$465 |
|
3686
iShares Russell 2000 ETF
IWM
$81.9B
| $56.8K | ﹤0.01% |
270
-32,828
| -99% | -$6.55M |
|
3687
Zura Bio
ZURA
$556M
| $55.1K | ﹤0.01% |
21,456
-98,984
| -82% | -$351K |
|
3688
Denison Mines
DNN
$2.98B
| $54.6K | ﹤0.01% |
27,998
-115
| -0.4% | -$218 |
|
3689
Vuzix
VUZI
$225M
| $54.1K | ﹤0.01% |
44,690
+8,560
| +24% | +$14K |
|
3690
BioXcel Therapeutics
BTAI
$30M
| $53.1K | ﹤0.01% |
1,178
+294
| +33% | +$14K |
|
3691
AbCellera Biologics
ABCL
$2.95B
| $51.8K | ﹤0.01% |
+11,428
| New | +$58.3K |
|
3692
Cadiz
CDZI
$283M
| $51.7K | ﹤0.01% |
17,823
-62
| -0.3% | -$170 |
|
3693
Butterfly Network
BFLY
$2.53B
| $51.2K | ﹤0.01% |
47,407
-130,197
| -73% | -$140K |
|
3694
Citius Pharmaceuticals
CTXR
$18.8M
| $50.6K | ﹤0.01% |
2,254
-78
| -3% | -$1.42K |
|
3695
Redwire
RDW
$3.16B
| $49.8K | ﹤0.01% |
11,355
-28
| -0.2% | -$89 |
|
3696
Kaltura
KLTR
$249M
| $49.3K | ﹤0.01% |
36,520
-207
| -0.6% | -$322 |
|
3697
Seres Therapeutics
MCRB
$49.6M
| $48.7K | ﹤0.01% |
3,148
+298
| +10% | +$6.43K |
|
|
CMBM
3698
DELISTED
Cambium Networks
CMBM
| $48.3K | ﹤0.01% |
+11,202
| New | +$50.4K |
|
3699
Akebia Therapeutics
AKBA
$241M
| $47.3K | ﹤0.01% |
25,835
-3,336
| -11% | -$5.33K |
|
|
OPTN
3700
DELISTED
OptiNose
OPTN
| $46.9K | ﹤0.01% |
2,140
-18
| -0.8% | -$400 |
|
Similar funds
Invesco's Q1 2024 Portfolio in Review
As of Q1 2024, Invesco held 4,000 positions worth $466B, up 11% from $420B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Invesco's Q1 2024 filing shows 185 new, 2,081 increased, 1,463 reduced and 143 closed positions. Its largest new stake was Flutter Entertainment: 2,145,165 shares worth $424M. The largest sale was Yum China, an estimated $514M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2024 buy was Flutter Entertainment: 2,145,165 shares worth $424M.
- Invesco added most to Microsoft in Q1 2024, an estimated $673M increase.
- Invesco's biggest Q1 2024 reduction was Yum China, cutting an estimated $514M.
- Invesco fully exited Invesco S&P 500 Pure Growth ETF in Q1 2024, selling an estimated $251M.
- Invesco's ten largest holdings make up 16% of its $466B portfolio in Q1 2024.
- Invesco opened 185 new positions and closed 143 in Q1 2024.
- Invesco's portfolio value rose 11% quarter-over-quarter to $466B.
Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.